Somewhat Positive Media Coverage Somewhat Unlikely to Affect Intermolecular (IMI) Stock Price

Press coverage about Intermolecular (NASDAQ:IMI) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intermolecular earned a news sentiment score of 0.21 on Accern’s scale. Accern also gave media headlines about the semiconductor company an impact score of 45.3364782461814 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Separately, ValuEngine raised shares of Intermolecular from a “strong sell” rating to a “sell” rating in a report on Monday, August 7th.

Intermolecular (NASDAQ:IMI) traded down $0.07 during trading on Tuesday, reaching $1.25. 50,900 shares of the company traded hands, compared to its average volume of 43,930. Intermolecular has a 52-week low of $0.80 and a 52-week high of $1.65.

ILLEGAL ACTIVITY WARNING: This report was first posted by Week Herald and is the property of of Week Herald. If you are accessing this report on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this report can be accessed at

About Intermolecular

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with's FREE daily email newsletter.

Leave a Reply